Investing Profile

Vineeta Agarwala

VCInvestor
General Partner @a16z; Physician @Stanford
a16z.com/author/vineeta-agarw...San Francisco Bay Area
Photo of Vineeta Agarwala, General Partner at Andreessen Horowitz
Your Intro Paths to Vineeta Agarwala

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Vineeta Agarwala on

cb
Current Investing Position
Andreessen Horowitz General Partner
Investment Range
$10K - $100.0M
Sweet Spot
$10.0M
Investments On Record
24
Current Fund Size
$2.2B

Vineeta Agarwala is on these Sector & Stage Rankings

Vineeta Agarwala's Investments On Record (17)

CompanyStageDateRound SizeTotal Raised
Arda Therapeutics
Series AOct 2024$43M
$43M
Co-investors: Matthew Caspari (Alumni Ventures ), Konstantin von Unger
Thyme Care
Series CJul 2024$55M
Series BAug 2023$60M
Series AOct 2021$22M
$140M
Co-investors: Kurt Sheline (Echo Health Ventures), Brenton Fargnoli (AlleyCorp), Vijay Patel (CVS Health), David Whelan (Town Hall Ventures), Vivek Garipalli
Pomelo Care
Series BJun 2024$46M
Series AJun 2023$33M
$79M
Co-investors: Josh Kopelman (First Round Capital)
Santa Ana Bio
Series BJun 2024$130M
$170M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Christine Borowski (Access Biotechnology), Jerel Davis (Versant Ventures), Peter Emtage (Versant Ventures), Shinichiro Fuse
Valar Labs
Series AMay 2024$22M
$26M
Co-investors: James Hardiman (DCVC (Data Collective)), Cavin Mozarmi (REMUS Capital), Nikita Andersson (Hummingbird Ventures), Steve Blank (M34 Capital), Johannes Schildt
knownwell
Series ADec 2023$20M
$25M
Co-investors: Ian Chiang (Flare Capital Partners), Larry Summers, Varsha Rao
Gate Bioscience
Series ANov 2023$60M
$60M
Co-investors: Scott Biller (GV (Google Ventures)), Jay Parrish (ARCH Venture Partners), Clare Ozawa (Versant Ventures)
Waymark
Series UnknownOct 2023$42M
Series AJan 2022$45M
$87M
Co-investors: Mohamad Makhzoumi (New Enterprise Associates (NEA))

most interested in

therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery